The group‐2 innate lymphoid cells (ILC2) slow abdominal aortic aneurysm (AAA) development by producing IL5 and IL13 to block smooth muscle cell (SMC) apoptosis and promote SMC proliferation. This evidence concerns the gene IL13 and triple-A syndrome.